If lawmakers want to make pharmaceuticals more affordable, they should look past populist policies like price controls that will only make matters worse and set their sights on reforming the Pharmacy ...

Two inmates booked into Jessamine County jail are charged with promoting contraband. During intake searches officers found suspected drugs concealed on each inmate. One inmate swallowed a substance; ...

Reviva Pharmaceuticals Inc. (NASDAQ: RVPH), a late clinical stage pharmaceutical company aiming to revolutionize the schizophrenia treatment market with Brilaroxazine, its developmental drug, made ...

A Monroe County judge sentenced a Florida Keys deputy on Monday to three years in prison for using the sheriff’s office computer database to provide her boyfriend with information about ongoing ...

COLORADO, USA — In the span of a week, federal investigators in Colorado announced the largest fentanyl seizure and the largest methamphetamine seizure ever recorded in the state — both tied to ...

Novartis NOVN0.72%increase; green up pointing triangle said higher expectations for key drugs and recent dealmaking that replenished its medicine pipeline should keep sales growing into the 2030s as ...

Novartis AG boosted its sales targets for two key cancer drugs, underscoring confidence in its oncology pipeline. The Swiss drugmaker raised its peak sales guidance for breast cancer drug Kisqali to ...

Marty Michel, owner of the Key Drugs location at 910 N. Westwood Blvd. in Poplar Bluff, has announced his retirement. The location will close Saturday, Nov. 29, with prescription records transferred ...

A common diabetes drug could dampen some of the key benefits of exercise, a new study has found. Researchers from Rutgers University discovered that adults who took metformin, a widely used generic ...

The MarketWatch News Department was not involved in the creation of this content. -- $12 million seed funding round led by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR ...

$12 million seed funding round led by Oxford Science Enterprises and Apollo Health Ventures, with AlbionVC, YZR Capital, and Parkwalk Advisors, and support from Oxford University Innovation Scripta ...